Predictive value of FDG-PET imaging for relapse in metastatic melanoma patients treated with immunotherapy.
C MesnardC Bodet-MilinT EugèneJ-M NguyenA KhammariBrigitte DrenoPublished in: Journal of the European Academy of Dermatology and Venereology : JEADV (2020)
Most patients with a PR on the CT scan and a CMR on the FDG-PET scan should be considered with a CR. Our study showed that FDG-PET imaging could play a crucial role in predicting the long-term outcome and help to decide whether treatment should be discontinued.